[
1. BUTNARIU A., IANCU M., SAMASCA G., CHIRA M., LUPAN I. Changes in NT-proBNP in young children with congenital heart malformations. LabMedicine 2014; 45:43-47.10.1309/LMAO4UY90YJQWKKP24719984
]Search in Google Scholar
[
2. PRONTERA C., ZUCCHELLI G.C., VITTORINI S., STORTI S., EMDIN M., CLERICO A. Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP. Clin Chim Acta 2009; 400:70-73.10.1016/j.cca.2008.10.01118992732
]Search in Google Scholar
[
3. ROSS R.D., BOLLINGER R.O., PINSKY W.W. Grading the severity of congestive heart failure in infants. Pediatr Cardiol 1992; 13:72-75.10.1007/BF007982071614922
]Search in Google Scholar
[
4. RUSCONI P.G., LUDWIG D.A., RATNASAMY C., MAS R., HARMON W.G., COLAN S.D., et al. Serial measurements of serum NT-proBNP as markers of left ventricular systolic function and remodeling in children with heart failure. Am Heart J 2010; 160:776-783.10.1016/j.ahj.2010.07.012296427920934575
]Search in Google Scholar
[
5. RATNASAMY C., KINNAMON D.D., LIPSHULTZ S.E., RUSCONI P. Associations between neurohormonal and inflammatory activation and heart failure in children. Am Heart J 2008; 155:527-533.10.1016/j.ahj.2007.11.00118294492
]Search in Google Scholar
[
6. ARQUES S. Contribution of natriuretic peptide testing and Doppler echocardiography at bedside to the diagnosis of acute heart failure. A practical overview. Minerva Cardioangiol 2012; 60:385-394.
]Search in Google Scholar
[
7. BUTNARIU A., ZAMFIR M., IANCU M., IACOB D., SAMASCA G., LUPAN I. Systolic and Diastolic Function in Congestive Heart Failure Pediatric Patients. Rom J Intern Med 2016:54:37–46.10.1515/rjim-2016-000427141569
]Search in Google Scholar
[
8. HINDERLITER A.L., BLUMENTHAL J.A., O’CONNER C., ADAMS K.F., DUPREE C.S., WAUGH R.A., et al. Independent prognostic value of echocardiography and N-terminal pro–B-type natriuretic peptide in patients with heart failure. Am Heart J 2008; 156:1191-1195.10.1016/j.ahj.2008.07.022366550419033018
]Search in Google Scholar
[
9. R CORE TEAM. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2012. ISBN 3-900051-07-0.
]Search in Google Scholar
[
10. BAGGISH A.L., VAN KIMMENADE R.R., JANUZZI J.L. The differential diagnosis of an elevated amino-terminal pro-B-type natriuretic peptide level. Am J Cardiol 2008; 101:43-48.10.1016/j.amjcard.2007.11.01918243858
]Search in Google Scholar
[
11. BAGGISH A.L., VAN KIMMENADE R.R., JANUZZI J.L. Amino-Terminal Pro-B-Type Natriuretic Peptide Testing and Prognosis in Patients with Acute Dyspnea, Including Those with Acute Heart Failure. Am J Cardiol 2008; 101:49A–55A.10.1016/j.amjcard.2007.11.02018243859
]Search in Google Scholar
[
12. SUGIMOTO M., MANABE H., NAKAU K., FURUYA A., OKUSHIMA K., FUJIYASU H., et al. The role of N-terminal pro-B-type natriuretic peptide in the diagnosis of congestive heart failure in children. Correlation with the heart failure score and comparison with B-type natriuretic peptide. Circ J 2010; 74:998-1005.10.1253/circj.CJ-09-053520378998
]Search in Google Scholar
[
13. ŞAHIN M., PORTAKAL O., KARAGÖZ T., HASÇELIK G., ÖZKUTLU S. Diagnostic performance of BNP and NT-ProBNP measurements in children with heart failure based on congenital heart defects and cardiomyopathies. Clin Biochem 2010; 43:1278–1281.10.1016/j.clinbiochem.2010.08.00220709045
]Search in Google Scholar
[
14. KANTOR P.F., RUSCONI P., LIPSHULTZ S., MITAL S., WILKINSON J.D., BURCH M. Current applications and future needs for biomarkers in pediatric cardiomyopathy and heart failure: Summary from the Second International Conference on Pediatric Cardiomyopathy. Prog Pediatr Cardiol 2011; 32:11–14.10.1016/j.ppedcard.2011.06.003316716621909230
]Search in Google Scholar
[
15. WONG D.T., GEORGE K., WILSON J., MANLHIOT C., MCCRINDLE B.W., ADELI K., et al. Effectiveness of serial increases in amino-terminal pro-B-type natriuretic peptide levels to indicate the need for mechanical circulatory support in children with acute decompensated heart failure. Am J Cardiol 2011; 107:573-578.10.1016/j.amjcard.2010.10.01521295174
]Search in Google Scholar
[
16. SANTHANAKRISHNAN R., CHONG J.P., NG T.P., LING L.H., SIM D., LEONG K.T., et al. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction. Eur J Heart Fail. 2012:14:1338-1347.10.1093/eurjhf/hfs13022869458
]Search in Google Scholar
[
17. NIETHAMMER M., SIEBER M., VON HAEHLING S., ANKER S.D., MUNZEL T., HORSTICK G., et al. Inflammatory pathways in patients with heart failure and preserved ejection fraction. Int J Cardiol 2008; 129:111–117.10.1016/j.ijcard.2007.05.06117658631
]Search in Google Scholar
[
18. DE DENUS S., LAVOIE J., DUCHARME A., O'MEARA E., RACINE N., SIROIS M.G., et al. Differences in biomarkers in patients with heart failure with a reduced vs a preserved left ventricular ejection fraction. Can J Cardiol 2012; 28:62-68.10.1016/j.cjca.2011.09.00722104539
]Search in Google Scholar
[
19. SCHOU M., GUSTAFSSON F., CORELL P., KISTORP C.N., KJAER A., HILDEBRANDT P.R. The relationship between N-terminal pro-brain natriuretic peptide and risk for hospitalization and mortality is curvilinear in patients with chronic heart failure. Am Heart J 2007; 154:123-129.10.1016/j.ahj.2007.04.00217584564
]Search in Google Scholar
[
20. JANUZZI J.L. The role of natriuretic peptide testing in guiding chronic heart failure management: review of available data and recommendations for use. Arch Cardiovasc Dis 2012; 105:40-50.10.1016/j.acvd.2011.10.00722369917
]Search in Google Scholar
[
21. CANTINOTTI M., CLERICO A., MURZI M., VITTORINI S., EMDIN M. Clinical relevance of measurement of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in pediatric cardiology. Clin Chim Acta. 2008; 390:12-22.10.1016/j.cca.2007.12.02018230356
]Search in Google Scholar
[
22. JOHNS M.C., STEPHENSON C. Amino-terminal Pro-B-type natriuretic peptide testing in neonatal and pediatric patients. Am J Cardiol 2008; 101:76-81.10.1016/j.amjcard.2007.11.02818243864
]Search in Google Scholar
[
23. LOWENTHAL A., CAMACHO B.V., LOWENTHAL S., NATAL-HERNANDEZ L., LISZEWSKI W., HILLS N.K., et al. Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease. Am J Cardiol 2012; 109:866-872.10.1016/j.amjcard.2011.10.049329419422196786
]Search in Google Scholar
